271 related articles for article (PubMed ID: 20600306)
1. Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives.
López-Novoa JM; Martínez-Salgado C; Rodríguez-Peña AB; López-Hernández FJ
Pharmacol Ther; 2010 Oct; 128(1):61-81. PubMed ID: 20600306
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
3. [Hypertension and renal disease].
Kamper AL; Pedersen EB; Strandgaard S
Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
[TBL] [Abstract][Full Text] [Related]
4. The role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease.
Norris K; Vaughn C
Expert Rev Cardiovasc Ther; 2003 May; 1(1):51-63. PubMed ID: 15030297
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease.
Morita S; Fukuhara S; Akizawa T; Asano Y; Koshikawa S; Koide K; Kurokawa K
Ther Apher Dial; 2006 Feb; 10(1):72-7. PubMed ID: 16556140
[TBL] [Abstract][Full Text] [Related]
6. Progression of chronic kidney disease: can it be prevented or arrested?
Jaber BL; Madias NE
Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
[TBL] [Abstract][Full Text] [Related]
7. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
8. The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented.
Bakris GL; Ritz E;
J Hypertens; 2009 Mar; 27(3):666-9. PubMed ID: 19262237
[TBL] [Abstract][Full Text] [Related]
9. [Reversal of renal fibrosis: lessons from experimental models].
Dussaule JC; Chatziantoniou C
Bull Acad Natl Med; 2008 May; 192(5):987-1000; discussion 1000-1. PubMed ID: 19238788
[TBL] [Abstract][Full Text] [Related]
10. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease.
Yamamoto T; Nakagawa T; Suzuki H; Ohashi N; Fukasawa H; Fujigaki Y; Kato A; Nakamura Y; Suzuki F; Hishida A
J Am Soc Nephrol; 2007 May; 18(5):1558-65. PubMed ID: 17409316
[TBL] [Abstract][Full Text] [Related]
11. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
[TBL] [Abstract][Full Text] [Related]
12. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD.
Onuigbo MA
Ren Fail; 2010; 32(8):954-8. PubMed ID: 20722563
[TBL] [Abstract][Full Text] [Related]
13. Importance of modulating the renin-angiotensin system in preventing renal complications of hypertension.
Rayner B
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):469-80. PubMed ID: 17186680
[TBL] [Abstract][Full Text] [Related]
14. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
15. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial.
Cortés-Sanabria L; Cabrera-Pivaral CE; Cueto-Manzano AM; Rojas-Campos E; Barragán G; Hernández-Anaya M; Martínez-Ramírez HR
Am J Kidney Dis; 2008 May; 51(5):777-88. PubMed ID: 18436088
[TBL] [Abstract][Full Text] [Related]
16. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a role of uromodulin in chronic kidney disease progression.
Prajczer S; Heidenreich U; Pfaller W; Kotanko P; Lhotta K; Jennings P
Nephrol Dial Transplant; 2010 Jun; 25(6):1896-903. PubMed ID: 20075439
[TBL] [Abstract][Full Text] [Related]
18. Hypertension in children with chronic kidney disease.
Shatat IF; Flynn JT
Adv Chronic Kidney Dis; 2005 Oct; 12(4):378-84. PubMed ID: 16198277
[TBL] [Abstract][Full Text] [Related]
19. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
Jones C; Roderick P; Harris S; Rogerson M
Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
[TBL] [Abstract][Full Text] [Related]
20. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
